| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,733.18 | 4,014.40 | | High | 13,755.76 | 4,030.00 | | Low | 13,581.04 | 3,976.25 | | Today's Cls | 13,607.04 | 3,984.95 | | Prev Cls | 13,695.58 | 4,013.35 | | Change | -88.54 | -28.40 | | % Change | -0.65 | -0.71 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Alfa Laval | 981.60 | 9.32 | | Syngenta | 551.15 | 7.52 | | Birla Corporation | 220.70 | 5.62 | | Syndicate Bank | 70.35 | 5.31 | | Balaji Telefilms | 160.15 | 4.95 | | Losers | | Hexaware | 170.50 | -7.44 | | BEL | 1,670.70 | -5.30 | | Satyam Computer | 455.90 | -4.89 | | Container Corporation | 1,990.00 | -4.80 | | CMC | 1,146.50 | -4.51 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,085 | 559 | | Declines | 1,463 | 828 | | Unchanged | 83 | 32 | | Volume(Nos) | 23.22cr | 37.48cr | | | | | | Market Commentary | | | Sensex slips amid lacklustre trades | | Heavy selling in information technology stocks and lack of buying support in the pivotals saw the Sensex shed 89 points. | | The Sensex opened on a positive note at 13733. However it could not hold on to the gains and drifted into negative territory. The market appeared extremely | | | bearish as the trading session progressed. Hectic selling in heavyweight, information technology, metal and consumer durables stocks in the afternoon dragged the index to the day's low of 13581. The Sensex ended the session with losses of 89 points at 13607, while the Nifty shed 28 points to close at 3985.
The breadth of the market was weak. Of the 2,631 stocks traded on the BSE, 1,463 stocks declined, 1,085 stocks advanced and 83 stocks ended unchanged. All the sectoral indices closed on a weak note. The BSE IT Index declined 2.48% followed by the BSE Teck Index (down 1.80%), the BSE Metal Index (down 1.29%) and the BSE CD Index (down 1.15%). | | | Movers & Shakers | - Gemini Communication gained on reports that the company has secured an order worth Rs57.6 crore from the government of Punjab.
- Dr Reddy’s notched up gains on reports that the company is the first participant in the United States Pharmacopoeia's New Pharmaceutical Ingredient Verification Programme.
- Jet Airways moved up on investing multi-million dollars for the company’s growth.
| | | |
Several index heavyweights ended with losses. Satyam Computers led the slump and tumbled 4.89% at Rs456. Tata Motors dropped 2.64% at Rs731, TCS slumped 2.39% at Rs1,250, Cipla shed 2.34% at Rs236, Infosys lost 2.19% at Rs2,082, Wipro declined 2.11% at Rs574, Maruti slipped 2.02% at Rs762 and ITC was down 1.61% at Rs156. Select counters, however, logged steady gains. Bajaj Auto rose 2.71% at Rs2,548, ACC added 2.56% at Rs807, Gujarat Ambuja gained 1.34% at Rs114 and Reliance Industries was up 1.10% at Rs1,476.
Over 89 lakh ICRA shares changed hands on the BSE followed by IFCI (87.30 lakh shares), GV Films (84.28 lakh shares), Bellary (82.34 lakh shares) and Tata Teleservices (76.83 lakh shares).
Value-wise Reliance Industries clocked a turnover of Rs154 crore on the BSE followed by Tata Steel (Rs116 crore), TCS (Rs85 crore), Infosys (Rs75.83 crore) and Satyam Computers (Rs58.99 crore).
| | | | | | | | European Indices at 16:15 IST on 17-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6469.60 | -46.60 | -0.72 | | CAC 40 Index | 5825.95 | -36.02 | -0.61 | | DAX Index | 7299.21 | -38.85 | -0.53 | | | | | | | | | | | Asian Indices at close on 17-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17527.45 | -100.85 | -0.57 | | Hang Seng Index | 20788.61 | 31.08 | 0.15 | | Kospi Index | 1528.66 | -3.38 | -0.22 | | Straits Times Index | 3415.32 | 1.17 | 0.03 | | Jakarta Composite Index | 1965.44 | 1.62 | 0.08 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
